Reuters reports Corxel will list in the US by merging with Amanat Acquisition Corp, a special purpose acquisition company.
Recap by typeshit. Full story at U.S. News Money.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
SURMOUNT-5 showed 20.2% average loss on tirzepatide versus 13.7% on semaglutide. Mounjaro brought in $8.7 billion in Q1 2026, ahead of Keytruda's $7.9 billion.
8:37
A personal video update from the 63 & Counting channel on six months of tirzepatide and more than 50 pounds down.
Loading…